Skip to main content
Caplight Logo









Mintech-Bio

Mintech-Bio

Private
NottinghamHealthcare & Life Scienceshttps://www.mintech.bio/

Last Round

Grant

Mar 1, 2024

Est. Valuation

$45.07M

Total Funding Raised

$980,000

Company Overview

Mintech-Bio operates in Healthcare & Life Sciences and is based in Nottingham. Its latest recorded funding round was a Grant round in March 2024.

Mintech-Bio is a biotechnology company that develops innovative dental solutions, including a protein-based gel designed to regenerate and remineralize tooth enamel.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Mintech-Bio Comparables

Compare Mintech-Bio with similar companies based on industry and business-model similarity.

Mintech-Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Auxomel
86%
Eterna Regeneratives
81%
HysensBio
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Mintech-Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2024
GrantFeb 1, 2024
VC RoundJun 29, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Mintech-Bio Investors

Notable investors and investment history

Mintech-Bio investors
InvestorRounds
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2024

    $560K raised from Innovate UK

  • Jun 29, 2023

    Raised $9.5M in a VC Round.

Book a demo to see all signals

For institutional investors. Book with your work email.

Mintech-Bio Filings

Explore SEC and related filing metadata, where available.

Mintech-Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Mintech-Bio's valuation, stock price, and market status.

Is Mintech-Bio a public or private company?

Mintech-Bio is a private company.

What is the current stock price of Mintech-Bio?

Mintech-Bio is a private company, so its shares have no public market price. Caplight tracks Mintech-Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Mintech-Bio worth (valuation)?

Mintech-Bio's valuation is estimated at $45.1M based on funding round data.

Can I buy Mintech-Bio stock?

Mintech-Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Mintech-Bio's last funding round?

Mintech-Bio's most recent funding round was Grant on March 1, 2024.

Who are the main investors in Mintech-Bio?

Key investors in Mintech-Bio include Innovate UK.

Will Mintech-Bio IPO soon?

No public IPO plans have been announced for Mintech-Bio.

How can I track Mintech-Bio secondary market activity?

Caplight tracks bids, offers, and trades in Mintech-Bio's shares on secondary markets.

Firmographic Details

HeadquartersNottingham
Year Founded2024
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?